18-21-10　ⓔ文献

  1. Craigen WJ, Darras BT: Glycogen debrancher deficiency (glycogen storage disease III). Hahn S (ed.) UpToDate (Hahn S, TePas E, eds), UpToDate Inc, https://www.uptodate.com

  2. Dagli A, Sentner CP, et al: Glycogen storage disease type III. GeneReviews (Adam MP, Ardinger HH, et al eds), University of Washington, 2016. https://www.ncbi.nlm.nih.gov/books/n/gene/gsd3/

  3. Goldberg T, Slonim AE: Nutrition therapy for hepatic glycogen storage diseases. J Am Diet Assoc, 1993; 93: 1423–1430.

  4. Dagli AI, Zori RT, et al: Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis, 2009; 32: S103–S106.

  5. Sentner CP, Caliskan K, et al: Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient. JIMD Rep, 2012; 5: 13–16.

  6. Vissing J, Haller RG: The effect of oral sucrose on exercise tolerance in patients with McArdle’s disease. N Engl J Med, 2003; 349: 2503–2509.

  7. Andersen ST, Haller RG, et al: Effect of oral sucrose shortly before exercise on workcapacity in McArdle disease. Arch Neurol, 2008; 65: 786–789.

  8. Sato S, Ohi T, et al: Confirmation of the efficacy of vitamin B6 supplementation for McArdle disease by follow–up muscle biopsy. Muscle Nerve, 2012; 45: 436–440.